SCHEMBL8359074

SCHEMBL8359074

O=C(O)c1ccc(CNC(=O)c2cc(C#CCc3ccccc3)ccn2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 11/20 0.51
NR1H4 Q96RI1 3/20 0.47
EPHX2 P34913 2/20 0.47
ROCK2 O75116 1/20 0.45
RPS6KA5 O75582 1/20 0.45
MAP4K4 O95819 1/20 0.45
PRKCG P05129 1/20 0.45
PRKACA P17612 1/20 0.45
RPS6KB1 P23443 1/20 0.45
MAPK1 P28482 1/20 0.45
AKT1 P31749 1/20 0.45
GSK3A P49840 1/20 0.45
GSK3B P49841 1/20 0.45
PRKX P51817 1/20 0.45
PRKCD Q05655 1/20 0.45
PRKG2 Q13237 1/20 0.45
ROCK1 Q13464 1/20 0.45
DYRK1A Q13627 1/20 0.45
PRKG1 Q13976 1/20 0.45
PKN2 Q16513 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6238788 0.79 SMN1; SMN2 (0.56) MMP13NR1H4EPHX2ROCK2RPS6KA5
SCHEMBL6230534 0.78 NR1H4 (0.55) MMP13NR1H4EPHX2ROCK2RPS6KA5
SCHEMBL6231446 0.75 GAA (0.56) MMP13NR1H4EPHX2MAPK1
SCHEMBL8358422 0.75 MMP13 (0.68) MMP13ROCK2RPS6KA5MAP4K4PRKCG
SCHEMBL6234382 0.74 NR1H4 (0.56) MMP13NR1H4EPHX2PTGER4
SCHEMBL6264658 0.74 NR1H4 (0.56) MMP13NR1H4EPHX2
SCHEMBL6234969 0.74 NR1H4 (0.56) MMP13NR1H4EPHX2PTGER4
SCHEMBL6231783 0.74 MMP13 (0.53) MMP13NR1H4EPHX2ROCK2ROCK1
SCHEMBL6271126 0.73 MMP13 (0.54) MMP13NR1H4EPHX2MAPK1
SCHEMBL17132817 0.72 MMP13 (0.71) MMP13NR1H4EPHX2PTGER4EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003032999-A1 ALKYNE MATRIX METALLOPROTEINASE INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2003-04-24 WO disclosed